In Brief: Pall Corporation
This article was originally published in The Gray Sheet
Executive Summary
Pall Corporation: Enters an agreement in principle to acquire for $41 mil. the assets of Bayer Corporation's Medical Plastics business, which manufacturers disposable plastic products and preservative solutions for blood collection and storage. The deal builds on an existing collaboration between the firms. Bayer's blood collection sets have incorporated Pall's leukocyte depletion filters since 1990, and Pall is the sales representative for European and U.S. sales of Bayer products using its filters....